Isomorphic Labs, a drug discovery company originating from Google DeepMind, is reportedly in discussions to secure approximately $5 billion in funding. This potential investment would place the company's valuation near $50 billion. The firm previously raised $2.1 billion in May, with Thrive Capital leading the round and Alphabet participating as an investor. AI
IMPACT This substantial funding could accelerate AI-driven drug discovery and development.
RANK_REASON Significant funding round for an AI-adjacent company. [lever_c_demoted from significant: ic=1 ai=0.7]
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →